These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351. Shen X; Tang H; Pajon R; Smith G; Glenn GM; Shi W; Korber B; Montefiori DC N Engl J Med; 2021 Jun; 384(24):2352-2354. PubMed ID: 33826819 [No Abstract] [Full Text] [Related]
8. Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2. Lustig Y; Nemet I; Kliker L; Zuckerman N; Yishai R; Alroy-Preis S; Mendelson E; Mandelboim M N Engl J Med; 2021 Jun; 384(25):2453-2454. PubMed ID: 33826815 [No Abstract] [Full Text] [Related]
9. Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization. Wang GL; Wang ZY; Duan LJ; Meng QC; Jiang MD; Cao J; Yao L; Zhu KL; Cao WC; Ma MJ N Engl J Med; 2021 Jun; 384(24):2354-2356. PubMed ID: 33822491 [No Abstract] [Full Text] [Related]
11. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. Liu J; Liu Y; Xia H; Zou J; Weaver SC; Swanson KA; Cai H; Cutler M; Cooper D; Muik A; Jansen KU; Sahin U; Xie X; Dormitzer PR; Shi PY Nature; 2021 Aug; 596(7871):273-275. PubMed ID: 34111888 [TBL] [Abstract][Full Text] [Related]
12. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera. Muik A; Lui BG; Wallisch AK; Bacher M; Mühl J; Reinholz J; Ozhelvaci O; Beckmann N; Güimil Garcia RC; Poran A; Shpyro S; Finlayson A; Cai H; Yang Q; Swanson KA; Türeci Ö; Şahin U Science; 2022 Feb; 375(6581):678-680. PubMed ID: 35040667 [TBL] [Abstract][Full Text] [Related]
15. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants. Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181 [TBL] [Abstract][Full Text] [Related]
16. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. Widge AT; Rouphael NG; Jackson LA; Anderson EJ; Roberts PC; Makhene M; Chappell JD; Denison MR; Stevens LJ; Pruijssers AJ; McDermott AB; Flach B; Lin BC; Doria-Rose NA; O'Dell S; Schmidt SD; Neuzil KM; Bennett H; Leav B; Makowski M; Albert J; Cross K; Edara VV; Floyd K; Suthar MS; Buchanan W; Luke CJ; Ledgerwood JE; Mascola JR; Graham BS; Beigel JH; N Engl J Med; 2021 Jan; 384(1):80-82. PubMed ID: 33270381 [No Abstract] [Full Text] [Related]
17. Correlation of vaccine-elicited antibody levels and neutralizing activities against SARS-CoV-2 and its variants. Liu J; Bodnar BH; Padhiar NH; Khan AI; Meng F; Saribas S; Wang P; Wang X; McCluskey E; Shah S; Zhao H; Luo JJ; Hu WH; Ho WZ Clin Transl Med; 2021 Dec; 11(12):e644. PubMed ID: 34923762 [No Abstract] [Full Text] [Related]
18. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM Front Immunol; 2021; 12():728021. PubMed ID: 34646267 [TBL] [Abstract][Full Text] [Related]
19. Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses. Tauzin A; Gong SY; Beaudoin-Bussières G; Vézina D; Gasser R; Nault L; Marchitto L; Benlarbi M; Chatterjee D; Nayrac M; Laumaea A; Prévost J; Boutin M; Sannier G; Nicolas A; Bourassa C; Gendron-Lepage G; Medjahed H; Goyette G; Bo Y; Perreault J; Gokool L; Morrisseau C; Arlotto P; Bazin R; Dubé M; De Serres G; Brousseau N; Richard J; Rovito R; Côté M; Tremblay C; Marchetti GC; Duerr R; Martel-Laferrière V; Kaufmann DE; Finzi A Cell Host Microbe; 2022 Jan; 30(1):97-109.e5. PubMed ID: 34953513 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people. Narowski TM; Raphel K; Adams LE; Huang J; Vielot NA; Jadi R; de Silva AM; Baric RS; Lafleur JE; Premkumar L Cell Rep; 2022 Feb; 38(5):110336. PubMed ID: 35090596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]